CNSY
Price:
$2.03
Market Cap:
$13.97M
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
Industry
Medical - Pharmaceuticals
IPO Date
2026-08-03
Stock Exchange
NASDAQ
Ticker
CNSY
According to Cerenome, Inc.’s latest financial reports and current stock price. The company's current ROE is -394.17%. This represents a change of 247.74% compared to the average of -113.35% of the last 4 quarters.
The mean historical ROE of Cerenome, Inc. over the last ten years is -169.30%. The current -394.17% ROE has changed 132.82% with respect to the historical average. Over the past ten years (40 quarters), CNSY's ROE was at its highest in in the September 2019 quarter at 328.75%. The ROE was at its lowest in in the March 2020 quarter at -1278.82%.
Average
-169.30%
Median
-221.24%
Minimum
-938.53%
Maximum
987.83%
Discovering the peaks and valleys of Cerenome, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 288.15%
Maximum Annual ROE = 987.83%
Minimum Annual Increase = -486.29%
Minimum Annual ROE = -938.53%
| Year | ROE | Change |
|---|---|---|
| 2025 | -560.21% | -486.29% |
| 2024 | 145.02% | -85.32% |
| 2023 | 987.83% | -414.01% |
| 2022 | -314.58% | 154.41% |
| 2021 | -123.65% | -54.52% |
| 2020 | -271.89% | -71.03% |
| 2019 | -938.53% | 288.15% |
| 2018 | -241.80% | 38.56% |
| 2017 | -174.51% | -13.04% |
| 2016 | -200.67% | 30.68% |
The current ROE of Cerenome, Inc. (CNSY) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
190.88%
5-year avg
26.88%
10-year avg
-169.30%
Cerenome, Inc.’s ROE is
| Company | ROE | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cerenome, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cerenome, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Cerenome, Inc.'s ROE?
How is the ROE calculated for Cerenome, Inc. (CNSY)?
What is the highest ROE for Cerenome, Inc. (CNSY)?
What is the 3-year average ROE for Cerenome, Inc. (CNSY)?
What is the 5-year average ROE for Cerenome, Inc. (CNSY)?
How does the current ROE for Cerenome, Inc. (CNSY) compare to its historical average?